CHTR vs ESLAW
Charter Communications Inc (CHTR) versus Estrella Immunopharma Inc. (ESLAW) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2026-06-30 was $13.53B. Net income was $1.29B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
ESLAW does not have a complete income-statement cache yet.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. ESLAW currently screens at market cap $0.
Not investment advice. Open the CHTR and ESLAW stock pages for the full models.
Not investment advice.